Skip to main content
GEHC
NASDAQ Industrial Applications And Services

GE HealthCare Q2: 5.7% Revenue Growth, Tariff Refunds Lift Margins, but PCS Stumbles

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$67.8
Mkt Cap
$29.163B
52W Low
$58.75
52W High
$89.77
52W Position info
15% above low
Off High info
24% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

GEHC sits 15% above its 52-week low of $58.75.

Summary

Second-quarter revenue reached $5.3 billion, up 5.7%, with tariff refunds bolstering profits. However, losses in the PCS segment and lingering legal and leadership issues cloud the outlook.


Key Events · Earnings and Guidance · GEHC

  • Revenue Growth Led by AIS and PDx

    Total revenues rose 5.7% to $5.3 billion, powered by a 7.9% jump in Advanced Imaging Solutions and a 15.6% surge in Pharmaceutical Diagnostics. Patient Care Solutions, however, fell 13.3% as operational and fulfillment headwinds persisted.

  • Tariff Refunds Boost Margins

    A $106 million pre-tax benefit from IEEPA tariff refunds—with $107 million already in cash and a $38 million receivable—helped offset incremental tariff costs and lifted gross margin.

  • PCS Segment Swings to Loss

    Patient Care Solutions swung to a Segment EBIT loss of $26 million, a sharp reversal from the $60 million profit a year ago, as volume declines and cost inflation bit.

  • Segment Realignment

    The company merged its Imaging and Advanced Visualization Solutions businesses into a new Advanced Imaging Solutions segment, restating historical results accordingly.


Analysis · GEHC · Industrial Applications And Services

GE HealthCare posted a solid second quarter, with revenue climbing 5.7% to $5.3 billion on the back of strength in Advanced Imaging Solutions and Pharmaceutical Diagnostics. Margins got a lift from a $106 million pre-tax benefit tied to tariff refunds, yet the Patient Care Solutions segment swung to an operating loss as operational challenges took their toll. The period also brought a segment realignment and ongoing share buybacks, while a CFO transition and a securities fraud investigation add a layer of uncertainty.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, GEHC was trading at $67.80 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $29.2B. The 52-week trading range was $58.75 to $89.77. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GEHC - Latest Insights

GEHC
Oct 28, 2026, 1:18 PM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $76.88
Real-time Price: $83.66 info
Change: +$6.78 (+9%) info
Market Cap: $37.826B info
GEHC
Oct 28, 2026, 6:26 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $74.90
Real-time Price: $83.66 info
Change: +$8.76 (+12%) info
Market Cap: $37.826B info
GEHC
Oct 28, 2026, 6:25 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $74.90
Real-time Price: $83.66 info
Change: +$8.76 (+12%) info
Market Cap: $37.826B info
GEHC
Oct 28, 2026, 6:20 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $71.59
Real-time Price: $83.66 info
Change: +$12.07 (+17%) info
Market Cap: $37.826B info
GEHC
Oct 05, 2026, 7:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $65.43
Real-time Price: $83.66 info
Change: +$18.23 (+28%) info
Market Cap: $37.826B info